The studies by Baumeister et al. and Kong et al. both provided gene expression data from CD34+ precursor cell populations derived from the BM of healthy individuals, MPN patients and patients with sAML derived from MPN (42,43). The gene discussed is CD34; the disease is myeloproliferative disorder.